AGILeBiotics Overview
- Year Founded
-
2017
- Status
-
Out of Business
- Employees
-
2
- Latest Deal Type
-
Out of Business
- Investors
-
1
AGILeBiotics General Information
Description
Developer of novel antibiotics designed to treat patients infected by life-threatening hospital-acquired multidrug-resistant infections. The company's antibiotics are based on natural products that fight against infections caused by multi-drug resistant bacteria, enabling healthcare professionals to cure patients in intensive care units and offer them access to safe therapeutic alternatives.
Contact Information
Website
www.agilebiotics.comCorporate Office
- L.J. Zielstraweg 2
- 9713 GX Groningen
- Netherlands
Corporate Office
- L.J. Zielstraweg 2
- 9713 GX Groningen
- Netherlands
AGILeBiotics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 7. Out of Business | 18-Jul-2025 | Completed | Out of Business | |||
| 6. Grant | 28-Nov-2019 | Completed | Startup | |||
| 5. Early Stage VC | 18-Jul-2018 | Completed | Startup | |||
| 4. Seed Round | 01-Mar-2017 | Completed | Startup | |||
| 3. Grant | 01-Feb-2017 | Completed | Startup | |||
| 2. Accelerator/Incubator | Completed | Startup | ||||
| 1. University Spin-Out | 01-Jan-2017 | Completed | Startup |
AGILeBiotics Comparisons
Industry
Financing
Details
AGILeBiotics Competitors (14)
One of AGILeBiotics’s 14 competitors is Ability Pharma, a Private Equity-Backed company based in Cerdanyola, Spain.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Ability Pharma | Private Equity-Backed | Cerdanyola, Spain | ||||
| Genentech | Formerly VC-backed | South San Francisco, CA | ||||
| Gesynta Pharma | Venture Capital-Backed | Stockholm, Sweden | ||||
| Cardurion | Venture Capital-Backed | Burlington, MA | ||||
| Volastra | Venture Capital-Backed | New York, NY |
AGILeBiotics Patents
AGILeBiotics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| CA-3120940-A1 | Novel antibacterial 3"-derivatives of 4,6-disubstituted 2,5-dideoxystreptamine aminoglycoside antibiotics | Pending | 05-Dec-2018 | ||
| EP-3891162-A1 | Novel antibacterial 3"-derivatives of 4,6-disubstituted 2,5-dideoxystreptamine aminoglycoside antibiotics | Active | 05-Dec-2018 | ||
| US-20220127297-A1 | Novel antibacterial 3"-derivatives of 4,6-disubstituted 2,5-dideoxystreptamine aminoglycoside antibiotics | Inactive | 05-Dec-2018 | ||
| WO-2020115190-A1 | Novel antibacterial 3"-derivatives of 4,6-disubstituted 2,5-dideoxystreptamine aminoglycoside antibiotics | Inactive | 05-Dec-2018 | ||
| EP-3891162-B1 | Novel derivatives of n-3"-guanidino-2,5-dideoxy-5-fluoro-4,6-disubstituted-streptamine aminoglycoside antibiotics | Active | 05-Dec-2018 | C07D487/04 |
AGILeBiotics Signals
AGILeBiotics Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| University of Groningen | University |
AGILeBiotics FAQs
-
When was AGILeBiotics founded?
AGILeBiotics was founded in 2017.
-
Where is AGILeBiotics headquartered?
AGILeBiotics is headquartered in Groningen, Netherlands.
-
What is the size of AGILeBiotics?
AGILeBiotics has 2 total employees.
-
What industry is AGILeBiotics in?
AGILeBiotics’s primary industry is Pharmaceuticals.
-
Is AGILeBiotics a private or public company?
AGILeBiotics is a Private company.
-
What is AGILeBiotics’s current revenue?
The current revenue for AGILeBiotics is .
-
Who are AGILeBiotics’s investors?
University of Groningen has invested in AGILeBiotics.
-
Who are AGILeBiotics’s competitors?
Ability Pharma, Genentech, Gesynta Pharma, Cardurion, and Volastra are some of the 14 competitors of AGILeBiotics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process